RAFキナーゼ阻害剤としてのω-カルボキシアリール置換ジフェニル尿素

Japanese Patent JP3845792

B2

This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.

Dryle, burned
Dumas, Jack
Keel, Uday
Rowinger, Timothy Bee
William Jay, Scott
Smith, roger a
Wood, Jill Yee
Monahan, Mary Catherine
Natello, Reina
Renick, Joel
Sylbury, Robert N

JP2000593580A

November 15, 2006

January 12, 2000

Click for automatic bibliography generation  

Bayer corporation

C07C275/28; C07D213/81; A61K31/17; A61K31/18; A61K31/24; A61K31/33; A61K31/341; A61K31/40; A61K31/4035; A61K31/44; A61K31/4406; A61K31/4409; A61K31/4412; A61K31/4439; A61K31/4453; A61K31/495; A61K31/496; A61K31/535; A61K31/5355; A61K31/5375; A61K31/5377; A61K31/54; A61P35/00; A61P43/00; C07C275/20; C07C275/22; C07C275/24; C07C275/30; C07C275/32; C07C275/36; C07C275/40; C07C291/12; C07C311/29; C07C317/22; C07D207/09; C07D209/46; C07D209/48; C07D211/72; C07D211/78; C07D213/74; C07D213/75; C07D213/79; C07D213/82; C07D295/12; C07D295/13; C07D295/135; C07D295/18; C07D295/192; C07D307/14; C07D401/12; C07F7/18; A61K; C07C; C07D

JP2023337A
JP2022650A
JP57185219A

WO1999020617A1
US5447957
US4973675
WO1999032463A1
WO1995033458A1
WO1997017329A1
WO2000041698A1

Tetrahedron Letters,1996, Vol.37, No.38, p.6947-6950
Journal of Immunological Methods,1996, Vol.196, No.2, p.163-174

Akaoka Michio

Previous Patent: APPLICATION TOOL

Next Patent: METHOD FOR FORMING CLOTH PRODUCT HAVING SURFACE THERMOFORMED PART FROM FABRIC